Ayurcann Holdings Corp Stock Shares Outstanding

AYURF Stock  USD 0.02  0.03  57.69%   
Ayurcann Holdings Corp fundamentals help investors to digest information that contributes to Ayurcann Holdings' financial success or failures. It also enables traders to predict the movement of Ayurcann OTC Stock. The fundamental analysis module provides a way to measure Ayurcann Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ayurcann Holdings otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Ayurcann Holdings Corp OTC Stock Shares Outstanding Analysis

Ayurcann Holdings' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Ayurcann Holdings Shares Outstanding

    
  155.56 M  
Most of Ayurcann Holdings' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ayurcann Holdings Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Ayurcann Holdings Corp has 155.56 M of shares currently outstending. This is 13.84% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 72.8% higher than that of the company.

Ayurcann Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ayurcann Holdings' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Ayurcann Holdings could also be used in its relative valuation, which is a method of valuing Ayurcann Holdings by comparing valuation metrics of similar companies.
Ayurcann Holdings is currently under evaluation in shares outstanding category among its peers.

Ayurcann Fundamentals

About Ayurcann Holdings Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Ayurcann Holdings Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ayurcann Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ayurcann Holdings Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Ayurcann OTC Stock

Ayurcann Holdings financial ratios help investors to determine whether Ayurcann OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ayurcann with respect to the benefits of owning Ayurcann Holdings security.